News and blogs
413 results found.
Five years on, our family is living free from the restraints of blood cancer
Lisa, mum to Hugo, reflects on the impact that leukaemia has had on her family. From the path to diagnosis and the gruelling side effects of treatment, to Hugo finally finishing treatment. Now, they look forward to embracing every moment.
We've saved so many lives in the last 60 years, because of Susan.
Read Sylvia Gaunt's story about how Blood Cancer UK was started by her parents, after her sister Susan died with Leukaemia.
Does having blood cancer put you at greater risk from the coronavirus?
Find out if people with blood cancers are more likely to suffer severe and life-threatening COVID-19 than healthy individuals.
An announcement from Blood Cancer UK
An announcement from Blood Cancer UK
Shielding from Covid with a staycation - Jo's story
Find out about how Jo, who has Acute Lymphoblastic Leukemia (ALL) shielded from Covid this summer by having a staycation.
How could a coronavirus vaccine help people with blood cancer?
Find out how coronavirus vaccines work and their potential to protect people with blood cancer.
What can we learn from the Cancer Patient Experience Survey results?
Find out what the results from the Cancer Patient Experience Survey (CPES) and Covid-19 will have on blood cancer care.
We're calling on the government to #SaveOurShielders
We're calling on the government to Save Our Shielders
Does glyphosate found in weed killer cause lymphoma?
Find out more from Blood Cancer UK about glyphosate-based weed killers and the evidence that they could cause lymphoma.
EHA annual conference 2020: the promising future of blood cancer research
Blood Cancer UK rounds up the exciting breakthroughs in blood cancer research discussed at this year’s European Haematology Association conference.
Our view on the proposed pause in Covid-19 shielding
Read Blood Cancer UK's response to the proposed pause in Covid-19 shielding and find out what this means for people with blood cancer.
What effect is COVID-19 having on blood cancer research?
Find out how blood cancer research is being effected by the COVID-19 pandemic.
New research hope for those with a rare type of leukaemia
Blood Cancer UK research fellow, Dr Marc Mansour and his team, have come to understand more about why some types of T-cell acute lymphoblastic leukaemia (T-ALL) stop responding to chemotherapy, and how we might overcome it in the future.
Back to school with blood cancer
Read Blood Cancer UK's advice on whether children with blood cancer should go back to school during the Covid pandemic.
How should coronavirus shielding guidance for blood cancer change?
Read Blood Cancer UK's article on why Covid-19 shielding guidance for people with blood cancer needs to improve.
Common symptoms of coronavirus are also symptoms of blood cancer
Dr Alex Langridge (Haematology Registrar in the North East of England) explains the challenges of detecting blood cancer when symptoms are similar to coronavirus, and what can be done about it.
People with blood cancer now make up a bigger proportion of coronavirus intensive care patients
Our analysis shows the proportion of people in intensive care because of coronavirus – who also have blood cancer – increased between April and May.
Why are people with blood cancer being told to shield for 12 weeks?
Here's the information we have on why people with blood cancer are being asked to shield.
Meet Alison, our blood cancer clinical nurse specialist
Meet Alison Paterson, a blood cancer clinical nurse specialist and member of our Nurses Working Group. Find out on what it's like working on the front line during the coronavirus pandemic.
Coronavirus mental health crisis for people with blood cancer
Over half of people who are shielding from coronavirus are struggling with their mental health and nearly one in 10 say the impact is severe, our survey of people with blood cancer has found.
